Skip to main content
Premium Trial:

Request an Annual Quote

South Africa's CPGR Begins Offering Services Using Affymetrix Microarray Platform

NEW YORK (GenomeWeb News) – South Africa’s Centre for Proteomic and Genomic Research has begun offering genomic research services using Affymetrix’s GeneChip microarray platform, the Santa Clara, Calif.-based company said today.
The company said the center is using many GeneChip arrays, including the exon array and the SNP 6.0 for applications including molecular diagnostics research, large-scale genotyping, and seeking new ways to advance drug research and development in South Africa.
The CPGR, which was founded in 2006, aims to “facilitate high-quality research and enable the growth of existing southern African biotech companies,” the center’s managing director, Reinhard Hiller, said in a statement.
“The range of projects we work on is particularly diverse,” Hiller added, noting that the center would use Affy’s products for toxicology, gene expression, and genotyping studies.
The company did not provide more specifics about its deal with the CPGR, or the financial terms of the agreement.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.